| Douglas Lienesch, MD | |
|
4735 Ogletown Stanton Rd Ste 2201, Newark, DE 19713-8000 | |
| (302) 623-4390 | |
| Not Available |
| Full Name | Douglas Lienesch |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 35 Years |
| Location | 4735 Ogletown Stanton Rd Ste 2201, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124129747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD428000 (Pennsylvania) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | C1-0013313 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Union Hospital Of Cecil County | Elkton, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christiana Care Health Services Inc | 9739097569 | 1248 |
| Union Hospital Of Cecil County | 6901719822 | 170 |
News Archive
The decision to halt an HHS public service campaign that promoted breast-feeding "seems to be a matter of politics and economics," Wendy Orent, author of the book "Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease," writes in a Los Angeles Times opinion piece (Orent, Los Angeles Times, 9/30).
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.
AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.
A group of scientists led by Ramkumar Menon at The University of Texas Medical Branch at Galveston has gained new insights into what factors lead to preterm birth. This study is currently available in The American Journal of Pathology.
› Verified 1 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770568107 PECOS PAC ID: 9739097569 Enrollment ID: O20031201000477 |
News Archive
The decision to halt an HHS public service campaign that promoted breast-feeding "seems to be a matter of politics and economics," Wendy Orent, author of the book "Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease," writes in a Los Angeles Times opinion piece (Orent, Los Angeles Times, 9/30).
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.
AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.
A group of scientists led by Ramkumar Menon at The University of Texas Medical Branch at Galveston has gained new insights into what factors lead to preterm birth. This study is currently available in The American Journal of Pathology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Lienesch, MD 200 Hygeia Dr Ste 2300, Newark, DE 19713-2049 Ph: () - | Douglas Lienesch, MD 4735 Ogletown Stanton Rd Ste 2201, Newark, DE 19713-8000 Ph: (302) 623-4390 |
News Archive
The decision to halt an HHS public service campaign that promoted breast-feeding "seems to be a matter of politics and economics," Wendy Orent, author of the book "Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease," writes in a Los Angeles Times opinion piece (Orent, Los Angeles Times, 9/30).
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.
AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.
A group of scientists led by Ramkumar Menon at The University of Texas Medical Branch at Galveston has gained new insights into what factors lead to preterm birth. This study is currently available in The American Journal of Pathology.
› Verified 1 days ago
Shruti Puri, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 Fax: 302-733-5640 | |
Zaid A Ammari, M.D. M.P.H. Rheumatology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 Fax: 347-851-8707 | |
Dr. Suresh Trivedi, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 406, Newark, DE 19713 Phone: 302-368-2630 Fax: 302-368-1271 | |
Dr. Bradley Bley, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1096 Old Churchmans Rd, Newark, DE 19713 Phone: 302-655-9494 Fax: 302-351-4898 | |
Dr. Avinash Chandra, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 86 Omega Dr, Omega Professional Center, Building B-86, Newark, DE 19713 Phone: 302-366-1929 Fax: 302-366-1006 | |
Dr. Lucinda Li, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd Ste 5a43, Newark, DE 19718 Phone: 302-623-0188 | |
Dr. James Robinson Mcninch Iv, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1148 |